The hypothesis is that the preoperative Clinical Frailty Score (CFS) is a predictive factor for a loss in quality-adjusted life years (QALYs) one year after emergency cardiac surgery under cardiopulmonary bypass (CPB) in patients aged 75 years and older.
The advancement of structural cardiology, particularly with percutaneous valve interventions, offers new treatment options without the need for cardiopulmonary bypass (CPB). Despite an increase in the use of these techniques, some studies highlight a notable rise in CPB usage in patients aged 80 and over, from 13.8% in 2013 to 20.5% in 2022. In France, the population aged 85 and above is expected to triple by 2050, meaning more elderly patients will be eligible for CPB cardiac surgery. Several global studies have examined the outcomes of older individuals undergoing CPB cardiac surgery. While EuroSCORE II and STS scores are effective in predicting short-term mortality, they lack accuracy in predicting long-term mortality, particularly in frail patients, and do not assess quality of life. New tools to evaluate frailty, such as the Clinical Frailty Scale (CFS), are now used in preoperative assessments for planned cardiac interventions. Identifying frail elderly patients early is crucial for improving patient and family information on care plans, especially in high-risk surgeries. Even in emergencies, patients must remain involved in their health decisions, and multidisciplinary collaboration is vital for improving postoperative recovery and quality of life. Data will be collected : * Preoperative: During the anesthesia consultation: Calculation of the CFS (frailty assessment = CFS ≥ 4) EuroQoL 5D-5L (quality of life, with the index calculated with the French value set of the EuroQol), and routine care (renal function: urea, creatinine, albumin levels). * Postoperative (ICU and hospital): Collection of complication incidence, mortality (all causes and LATA-related). * Follow-up (by phone at 3, 6, and 12 months): CFS and EuroQoL scores, prevalence of chronic pain and analgesic use, dialysis dependency, accommodation status, readmission rates, and death date if applicable.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Phone calls will be made at 3, 6, and 12 months to report quality of life scores (EuroQol EQ 5D-5L) and other postoperative data
University Hospital, Bordeaux
Bordeaux, France, France
RECRUITINGQuality-Adjusted Life Years (QALYs) according to preoperative frailty status
QALYs over the 12-month follow-up will be estimated from EQ-5D-5L utility scores collected at baseline, Month 3, Month 6, and Month 12 together with survival data, and compared between participants with preoperative frailty (Clinical Frailty Scale ≥4) and those without frailty (Clinical Frailty Scale \<4), with adjustment for EuroSCORE II.
Time frame: Month 12
Postoperative complications
Incidence of postoperative cardiac, respiratory, renal, infectious, and neurological complications during the first 28 postoperative days.
Time frame: From surgery through,Day 28
All-cause mortality
All-cause mortality assessed during ICU stay, hospital stay, and at Month 3, Month 6, and Month 12.
Time frame: Through Month 12
EQ-5D-5L Utility Index
Health-related quality of life assessed using the EQ-5D-5L utility index derived from the French value set
Time frame: Baseline, Month 3, Month 6, and Month 12
Dialysis dependence
Dialysis dependence among participants not receiving chronic dialysis before surgery.
Time frame: Month 3, Month 6, and Month 12
Length of intensive care unit stay
Duration of postoperative ICU stay.
Time frame: From ICU admission to ICU discharge (assessed up to Day 28)
Length of hospital stay
Total postoperative hospital length of stay.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Masking
NONE
Enrollment
265
Time frame: From surgery to hospital discharge
Hospital readmissions
Number of hospital readmissions since discharge, assessed at each follow-up visit.
Time frame: Month 3, Month 6, and Month 12
Chronic postoperative pain
Presence of chronic pain related to cardiac surgery.
Time frame: Month 3, Month 6, and Month 12
Analgesic consumption
Type of analgesic medication and frequency of use since the previous follow-up assessment.
Time frame: Month 3, Month 6, and Month 12
Living situation
Living at home versus institutionalization during follow-up.
Time frame: Month 3, Month 6, and Month 12
EQ-5D-5L visual analogue scale (EQ VAS)
Self-rated health status assessed using the EQ-5D-5L visual analogue scale (0-100).
Time frame: Baseline, Month 3, Month 6, and Month 12